The concept of innovative drugs continues to rise. As of press release, Harbin Sanlian, Baihua Pharmaceutical, etc. have risen and stopped, while Yuheng Pharmaceutical, Longshen Rongfa, and Cube Pharmaceutical have followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.